Diagnostic test utilizing PET imaging with the radioactive drug, Copper 64 Dotatate. This scan identifies the location of somatostatin receptor positive Neuroendocrine tumors.
Diagnostic test utilizing PET imaging with the radioactive drug, Copper 64 Dotatate. This scan identifies the location of somatostatin receptor positive Neuroendocrine tumors.